Longeveron (LGVN) Current Leases (2022 - 2026)
Longeveron (LGVN) posted quarterly Current Leases of $688000.0 for Q1 2026, up 9.03% year-over-year from $631000.0 in Q1 2025, and up 5.04% quarter-over-quarter from $655000.0 in Q4 2025.
Longeveron (LGVN) Current Leases (2022 - 2026) Analysis & Trends
Longeveron's Current Leases history runs 5 years deep, the most recent figure standing at $688000.0 for Q1 2026.
- In Q1 2026, Current Leases rose 9.03% year-over-year to $688000.0; the TTM figure through Mar 2026 stood at $688000.0 (up 9.03% YoY), while the FY2025 annual figure was $655000.0, up 5.14% from the prior year.
- Current Leases for Q1 2026 stood at $688000.0, up from $655000.0 in the prior quarter.
- The five-year high for Current Leases was $688000.0 in Q1 2026, with the low at $564000.0 in Q4 2022.
- The 5-year median for Current Leases is $623000.0 (2024), against an average of $624090.9.
- The sharpest annual moves came in 2025 and 2026: Current Leases climbed 4.99% in 2025, then grew 9.03% in 2026.
- Longeveron's Current Leases stood at $564000.0 in 2022, then gained by 5.14% to $593000.0 in 2023, then gained by 5.06% to $623000.0 in 2024, then gained by 5.14% to $655000.0 in 2025, then grew by 5.04% to $688000.0 in 2026.
- Business Quant data shows LGVN's Current Leases at $688000.0 in Q1 2026, $655000.0 in Q4 2025, and $647000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Current Leases (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | 720.00 Mn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | - |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | 21.95 Mn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | 45.93 Mn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | - |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | 6.27 Mn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | - |
| 10 | Longeveron | 26.51 Mn | 16.41 Mn | 182,000.00 | 581,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 581,000.00 |
| Mar 31, 2026 | 688,000.00 |
| Dec 31, 2025 | 655,000.00 |
| Sep 30, 2025 | 647,000.00 |
| Jun 30, 2025 | 639,000.00 |
| Mar 31, 2025 | 631,000.00 |
| Dec 31, 2024 | 623,000.00 |
| Sep 30, 2024 | 616,000.00 |
| Jun 30, 2024 | 608,000.00 |
| Mar 31, 2024 | 601,000.00 |
| Dec 31, 2023 | 593,000.00 |
| Dec 31, 2022 | 564,000.00 |